Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
The purpose of this research study is to learn if a digital communication tool can improve how well patients with head and neck cancer and their caregivers understand the disease and treatment plan after their first consultation visit with the doctor/nurse practitioner.
調査の概要
詳細な説明
Primary Objective:
The primary objective of this pilot study is to determine whether use of a novel digital visual communication tool improves patient understanding and satisfaction with their initial multidisciplinary consultation for head and neck and prostate cancer. Specifically, the study seeks to answer the scientific question:
• Do at least 75% of newly diagnosed head and neck and prostate cancer patients report being "satisfied" (≥4 positive responses on a 6-item survey) after use of the digital communication tool, and is this proportion significantly greater than 50%?
Secondary Objectives:
Caregiver Understanding and Satisfaction
• What proportion of caregivers of newly diagnosed patients report satisfaction with their understanding of the patient's disease and treatment after using the tool, and how confident can we be in this estimate (95% Clopper-Pearson CI)?
Provider Experience and Communication Effectiveness
• What proportion of providers report satisfaction (≥5 positive responses on a 7-item survey) with the tool's ability to improve communication efficiency and consultation quality for patients they treated?
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Steven J Frank, MD
- 電話番号：(713) 563-3601
- メール：sjfrank@mdanderson.org
研究場所
-
-
Texas
-
Houston、Texas、アメリカ、77030
- UT MD Anderson
-
コンタクト：
- Steven J Frank, MD
- 電話番号：713-563-3601
- メール：sjfrank@mdanderson.org
-
主任研究者：
- Steven Frank, MD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
Patients
- Adults aged 18 to 100 years.
- Diagnosed with head and neck cancer (all histologies included).
- Receiving treatment for head and neck and prostate cancer at MDACC
- Able to speak and understand English
Caregivers
- Adults (≥18 years old).
- Identified as a caregiver to a patient who meets the above patient inclusion criteria.
- Able to speak and understand English.
Providers
- Doctors or nurse practitioners practicing in the field of radiation oncology and actively participating in initial consultations for patients with head and neck cancer and prostate cancer.
- Must complete the provider survey after the consultation.
Exclusion Criteria:
Patients
- Individuals without a diagnosis of head and neck cancer or prostate cancer.
- Patients who do not speak English (since the digital tool is not translated).
Caregivers
- Adults who are not caregivers of the eligible patient
- Caregivers who do not speak English (tool not translated).
Providers
- Doctors or nurse practitioners not practicing in the field of radiation oncology and not part of the initial consultation process.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：デバイスの実現可能性
- 割り当て：なし
- 介入モデル：単一グループの割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Patient/Caregiver: Use of MyCareGorithm
Following use of the digital visual communication tool by the provider, patients and any accompanying caregivers will be asked to complete their surveys via REDCap. Providers will complete their survey immediately after the consultation with each participating patient, also via REDCap. Each survey requires approximately 5 minutes to complete. No follow-up surveys or repeat administrations are planned. |
A 6-item structured questionnaire with Yes/No response options, followed by one open-ended free-text question. |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Safety and Adverse Events (AEs)
時間枠：Through study completion; an average of 1 year
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 |
Through study completion; an average of 1 year
|
協力者と研究者
捜査官
- 主任研究者：Steven J Frank, MD、UT MD Anderson
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 2026-1108
- NCI-2026-07264 (その他の識別子：NCI-CTRP Clinical Trials Registry)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。